Alzheimer’s Research UK announces ‘cannabis-based’ Sativex trial for dementia

The UK’s leading dementia research charity Alzheimer’s Research UK has announced it will fund a “pioneering” clinical trial at King’s College London using the “cannabis-based” treatment Sativex for people living with dementia. Sativex is a peppermint-flavoured mouth spray that contains a 1:1 ratio of two key cannabinoids found in the cannabis plant – delta-9-tetrahydrocannabinol (THC) […]

Continue Reading

Young adults turn away from alcohol problem fuelled by upper classes

The proportion of people drinking to excess in England has fallen slightly in the last year, largely because young adults – including the oft-maligned millenials – continue to turn away from alcohol. While rises in alcohol-related deaths and hospital admissions are growing in absolute terms – roughly in line with population growth – broadly stable […]

Continue Reading

WHO recommends rescheduling cannabis and descheduling pure CBD – reaction

The World Health Organization’s Expert Committee on Drug Dependence (ECDD) has told the United Nations Commission on Narcotic Drugs (CND) that cannabis and cannabis resin should be removed from Schedule IV of the 1961 Convention, the category reserved for the most dangerous substances.  In 1954 the WHO started an initiative to eradicate cannabis from the […]

Continue Reading